Module 2: Basic Pharmacology of Controlled Drugs and Substances
Lesson 1
Learning Activity:
Review these articles to enhance your understanding of the potential influence of pharmacogenetics and pharmacogenomics on controlled drugs and substances prescribing and client management.
- Kapur, B.M., Lala, J.K., & Shaw, P.L.V. (2014) – Pharmacogenetics of chronic pain management. Clinical Biochemistry, 47 (13 14), 1169-1187. doi: https://doi.org/10.1016/j.clinbiochem.2014.05.065
- Yiannakopoulou, E. (2015) Pharmacogenomics and opioid analgesics: Clinical Implications [electronic version]. International Journal of Genomics (PDF). doi:http://dx.doi.org/10.1155/2015/368979
- Pharmacogenomics and Opioid Analgesics: Clinical Implications.
- Hilal-Dandan, R. & Brunton, L. L. (Eds)(2014). Goodman and gilman’s manual of pharmacology and therapeutics (2nd ed.) New York: McGraw Hill.
- Kosten, T. R. & George, T. P. (2002). The neurobiology of opioid dependence: Implications for treatment. Science Practice Perspectives, 1(1), 13-20
- Sehgal, N., Manchikanti, L., & Smith, H.S. (2012). Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician Journal, 15, ES67-92.
